Seller review · priced all-in
KIN Health, priced
KIN separates introductory GLP-1 offers from later monthly charges and prices other products by supply or quantity. Refill language differs across its catalog, so one product’s no-auto-renew promise should not settle another order.
By Jenna Pratt, consumer-access reporter · Updated October 2026
Semaglutide injection
$169/moAll-in $169 a month, no fees on top.
Itemized bill
KIN Health
Semaglutide injection
Totals are our arithmetic from the seller’s published figures. The seller states no amount for laboratory testing, so none is counted.
The bill, in one line
Compare the ongoing GLP-1 amount rather than the opening discount. For other products, preserve the stated supply or quantity and confirm whether refills are automatic. The unreadable public contract and a named pharmacy’s FDA warning warrant answers before payment.
KIN Health is operated by KIN Medical, Inc. Its online catalog includes compounded semaglutide, tirzepatide, sermorelin, NAD+ and PT-141 through licensed-provider review. The seller offers different routes, strengths and quantities rather than one interchangeable monthly package. A prescription remains subject to clinical approval. Published delivery and support inclusions should be checked against the exact product selected and the final agreement.
The weight-loss page prints $99 for the first month, followed by $169 per month for semaglutide or $199 for tirzepatide. It limits the introductory offer to new patients at the starting dose. The homepage separately says the monthly price stays the same regardless of prescribed dose. The advertised regular figure is distinct from a verified checkout total. Other product pages price thirty-day supplies: sermorelin and NAD+ have different amounts for injection, nasal and dissolving routes. Those supply prices should not silently become calendar-month billing. PT-141 is priced by a five-milliliter injection vial, a five-milliliter nasal bottle or eight tablets. An on-demand quantity does not establish a month of use. Ask for the prescribed preparation and full amount due before comparing alternatives.
Every price, in the seller’s own unit
A per-vial price stays per vial. A calendar-month figure appears only where the seller’s unit carries one, and a cost per milligram only where the seller states how much the unit holds. Where the seller bills by the four-week fill or the package, or leaves a required fee outside its price, the calendar-month figure is our arithmetic and is marked as ours.
| Product | Seller’s price | Per calendar month | Per mg | Read |
|---|---|---|---|---|
| Semaglutide, injection | $169/mo | $169/mo | — | October 2026 |
| Tirzepatide, injection | $199/mo | $199/mo | — | October 2026 |
Lowest monthly, by form: Injection From $169/mo (Semaglutide)
Fees outside the headline
Clinical consultationincluded
Provider consultation and ongoing messaging are listed within the GLP-1 package.
Read October 2026
Medication deliveryincluded
The product pages advertise free delivery in discreet packaging.
Read October 2026
Separate membershipnone
The homepage states no membership fees.
Read October 2026
Laboratory testingnone stated
Review of results if needed does not establish payment for the laboratory test.
Read October 2026
See KIN Health’s current price
Semaglutide injection at $169/mo. Prices move; check the seller’s own page before you pay.
The fine print
- Prepay
- The GLP-1 offer is described by first and later months, without a published multi-month prepaid commitment on that page. The other products use thirty-day supply or package quantities. A stated supply does not establish the renewal interval or the maximum commitment. Confirm whether the purchase is one-time, recurring or tied to a longer plan. No annualized bill is inferred from an on-demand PT-141 package.
- Cancellation
- The GLP-1 page says there are no subscriptions, lock-in or automatic renewals and that the buyer approves each refill. Sermorelin, NAD+ and PT-141 pages instead advertise one-time or automatic refills. This is a product-level difference that must be resolved at ordering. The public terms page did not expose a readable agreement through the available text reader. No universal self-service cancellation method or pre-dispensing cutoff is established here. Product pages advertise a full refund if the clinician declines treatment; that promise does not establish a refund after dispensing or a satisfaction guarantee.
- Shipping
- KIN advertises free delivery in plain packaging across the states it serves. The GLP-1 package lists medication, supplies and an injection guide alongside provider consultation and messaging. Laboratory review if needed is not the same as paying for a laboratory test. Its GLP-1 page names Drug Crafters and Boothwyn. FDA’s 2026 human-drug warning to Boothwyn describes sterile-quality and specified semaglutide and tirzepatide failures. That record does not establish that an individual KIN order contains an affected lot. Confirm the assigned dispenser and how a damaged, delayed or recalled prescription is handled before accepting shipment.
Worth it, and what to watch
Worth it
- Regular GLP-1 prices separated from opening offer
- GLP-1 page explains buyer-approved refills
- Free shipping advertised
- Several product quantities and strengths stated
Watch for
- Refill promises vary across products
- Public contract unreadable through text reader
- Thirty-day supply is not a billing calendar
- Named pharmacy has a material FDA quality record
- Buy here if
- A buyer who will compare the regular amount, confirm the exact refill option and verify the dispenser before ordering.
- Look elsewhere if
- Someone relying on the first-month headline, an assumed annual total, or an unresolved automatic-refill agreement.
Price it elsewhere
Other sellers that publish a semaglutide injection price. Sellers we have reviewed come first, then sellers we have only priced; each group runs lowest price first.
FAQ
3 questionsIs $99 the continuing GLP-1 price?
No. The weight-loss page assigns $99 to the first month for eligible new starting-dose patients. It prints higher ongoing prices for semaglutide and tirzepatide.
Is a thirty-day supply a calendar-month subscription?
Not necessarily. The product page establishes a quantity of treatment, while the actual billing and renewal agreement must be confirmed separately.
Does declined treatment qualify for a refund?
The product pages advertise a full refund when the provider does not approve treatment. That does not establish a refund for an already dispensed prescription.
Price it at KIN Health
Every figure above was read from KIN Health’s own pages. The current one is a click away.
Before you buy
Questions the research answers
Other sellers we have priced
| Collective | $76/mo |
|---|---|
| Lean Meds | $79/mo |
| RxPepsDirect | $79/mo |
| Mondae | $87/mo |
| Enhanced | $89/mo |
| CoreAge Rx | $99/mo |
| Harbor | $99/mo |
| SnagRx | $99/mo |
Where every figure comes from
- Platform operator and separate-fee claims
- Opening and later GLP-1 charges
- Sermorelin price units
- NAD+ quantity and route choices
- PT-141 package sizes
- Boothwyn FDA quality record relevant to dispenser verification
- Drug Crafters historical inspection referral
- Compounded-drug status explained by FDA